Vir Biotechnology, Inc.
VIR
$5.09
-$0.325-6.01%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 20.86M | 74.21M | 78.62M | 78.88M | 79.60M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 20.86M | 74.21M | 78.62M | 78.88M | 79.60M |
| Cost of Revenue | 506.80M | 487.72M | 505.30M | 455.13M | 518.07M |
| Gross Profit | -485.94M | -413.51M | -426.68M | -376.26M | -438.47M |
| SG&A Expenses | 106.65M | 119.03M | 133.55M | 148.74M | 163.98M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 613.45M | 606.75M | 638.84M | 603.87M | 682.06M |
| Operating Income | -592.59M | -532.54M | -560.23M | -524.99M | -602.46M |
| Income Before Tax | -579.05M | -523.11M | -539.19M | -492.27M | -550.01M |
| Income Tax Expenses | -1.41M | -1.15M | -5.84M | -9.23M | -10.57M |
| Earnings from Continuing Operations | -577.65 | -521.96 | -533.34 | -483.04 | -539.44 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | 0.00 | 0.00 | 0.00 |
| Net Income | -577.65M | -521.96M | -533.34M | -483.04M | -539.44M |
| EBIT | -592.59M | -532.54M | -560.23M | -524.99M | -602.46M |
| EBITDA | -579.68M | -517.98M | -544.07M | -507.15M | -584.13M |
| EPS Basic | -4.22 | -3.83 | -3.92 | -3.58 | -4.01 |
| Normalized Basic EPS | -2.43 | -2.12 | -2.23 | -2.05 | -2.40 |
| EPS Diluted | -4.22 | -3.83 | -3.93 | -3.58 | -4.02 |
| Normalized Diluted EPS | -2.43 | -2.12 | -2.23 | -2.05 | -2.40 |
| Average Basic Shares Outstanding | 547.17M | 544.98M | 542.78M | 540.41M | 538.24M |
| Average Diluted Shares Outstanding | 547.17M | 544.98M | 542.78M | 540.41M | 538.24M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |